AzTrials
AzTrials

Eating DisordersNCT05140109

Trial on Three Eating Disorders Group Treatment

A study testing Arm 1: Cognitive-dissonance based program, Arm 2: Mindfulness-based program and Arm 3: Person-centered program in people with Eating Disorders, run by Université Lumière Lyon 2 at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This trial aims at comparing three group treatments designed for eating disorders: a Cognitive-dissonance, a Mindfulness and a Person-centered based programs. Women with eating disorders will be recruited and randomized to one of the three programs. Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Eating Disorders
What is being tested?
Arm 1: Cognitive-dissonance based program, Arm 2: Mindfulness-based program and Arm 3: Person-centered program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteFrance
Study dates
1 Sep 2018to 22 Sep 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • eating disorders (anorexia nervosa, bulimia nervosa or binge eating disorder) or other specified feeding or eating disorder (subthreshold of anorexia, bulimia or binge eating disorder) according to Diagnostic Statistical Manual 5
  • to have no regular treatment (no more than one session per month) during the 8 weeks of the program
  • participants with a Body Mass Index under 17.5 could be include in the study if they had a medical monitoring in another structure

Who cannot join

  • a psychotic disorder
  • a bipolar disorder
  • a mental retardation
  • to not read or speak French fluently

Trial locations and contacts

1 site in 1 country.

France1 site
  • Association Endat

    Paris, 75015

Other trials in France

About this study

Official title: Effectiveness Randomized Controlled Trial on Eating Disorders Group Treatment: a Cognitive Dissonance, a Mindfulness and a Person-centered Based Program

This trial aims at comparing three group treatments designed for eating disorders: a Cognitive-dissonance, a Mindfulness and a Person-centered based programs. Women with eating disorders will be recruited and randomized to one of the three programs. Participants will complete a pretest, a posttest, a 3-months follow-up and a 1-year follow-up. This trial aims to compare the programs to analyze the specific dimensions upon which each program acts. The investigators therefore made hypotheses according to the programs' theory: participants in the Cognitive-dissonance based program should experience a greater decrease in eating disorders symptoms, thin-ideal internalization and body dissatisfaction and a greater improvement in quality of life than other participants. Participants in the Mindfulness-based program should show a greater improvement in negative affect and in equanimity than other participants. Participants in the Person-Centered based program should report a greater increase in congruence than other participants.

Being tested
Arm 1: Cognitive-dissonance based program, Arm 2: Mindfulness-based program, Arm 3: Person-centered program
Medical subject headings
Feeding and Eating Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Arm 1: Cognitive-dissonance based programOther

    The first four sessions focus on body image and the last four sessions on eating behavior.

  • Arm 2: Mindfulness-based programOther

    The sessions focus on different contents as body image, eating behavior and emotion regulation.

  • Arm 3: Person-centered programOther

    The sessions are not structured. Participants can bring any subject they need to talk.

Study groups in NCT05140109
Study groupRoleWhat they receive
Cognitive-dissonance based programExperimentalGroup program of 8 sessions of one hour and a half.
Receives: Other: Arm 1: Cognitive-dissonance based program
Mindfulness-based programActive comparatorGroup program of 8 sessions of one hour and a half.
Receives: Other: Arm 2: Mindfulness-based program
Person-centered programActive comparatorGroup program of 8 sessions of one hour and a half.
Receives: Other: Arm 3: Person-centered program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mean change in The Eating Disorders Diagnostic Interview from pretest to 1-year follow-up

    The minimum of the scale is 0 and the maximum is 276. A higher score means a worse outcome.

    Measured: From pretest to 1-year follow-up

Secondary outcomes (6)
  1. Mean change in The Hospital Anxiety and Depression Scale from pretest to 1-year follow-up

    The minimum of the scale is 0 and the maximum is 42. A higher score means a worse outcome.

    Measured: From pretest to 1-year follow-up

  2. Mean change in the subscale "Body dissatisfaction" from the scale Eating disorders inventory-2 from pretest to 1-year follow-up

    The minimum of the scale is 0 and the maximum is 27. A higher score means a worse outcome.

    Measured: From pretest to 1-year follow-up

  3. Mean change in the Sociocultural Attitudes Towards Appearance Scale from pretest to 1-year follow-up

    The minimum of the scale is 0 and the maximum is 150. A higher score means a worse outcome.

    Measured: From pretest to 1-year follow-up

  4. Mean change in the World Health Organization Quality Of Life Scale from pretest to 1-year follow-up

    The minimum of the scale is 0 and the maximum is 20. A higher score means a better outcome.

    Measured: From pretest to 1-year follow-up

  5. Mean change in the Strathclyde Inventory measuring congruence from pretest to 1-year follow-up

    The minimum of the scale is 0 and the maximum is 4. A higher score means a better outcome.

    Measured: From pretest to 1-year follow-up

  6. Mean change in the Equanimity scale from pretest to 1-year follow-up

    The minimum of the scale is 0 and the maximum is 7. A higher score means a better outcome.

    Measured: From pretest to 1-year follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Dec 2021
  2. Study start1 Sep 2018
  3. Primary completion29 Jan 2021
  4. Study completion22 Sep 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
100 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05140109
Sponsor's protocol ID
2020-A02346-33a
Status last verified
Dec 2024
First submitted
5 Nov 2021
Last updated
9 Dec 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Arm 1: Cognitive-dissonance based program, Arm 2: Mindfulness-based program and Arm 3: Person-centered program in people with Eating Disorders, run by Université Lumière Lyon 2 at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mean change in The Eating Disorders Diagnostic Interview from pretest to 1-year follow-up (time frame: From pretest to 1-year follow-up). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Dec 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in